Networking in autism: Leveraging genetic, biomarker and model system findings in the search for new treatments

Neuropsychopharmacology

Volumn 37, Issue 1, 2012, Pages 196-212

  Veenstra Vanderweele, Jeremy ^a   Blakely, Randy D ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

FMR1; genetics; glutamate; mGluR5; serotonin transporter; translation

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); ARIPIPRAZOLE; AROMATIC LEVO AMINO ACID DECARBOXYLASE; ATYPICAL ANTIPSYCHOTIC AGENT; BIOLOGICAL MARKER; CITALOPRAM; CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RISPERIDONE; SEROTONIN; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TRYPTOPHAN HYDROXYLASE; TRYPTOPHAN HYDROXYLASE 2; VESICULAR MONOAMINE TRANSPORTER 2;

AUTISM; BLOOD BRAIN BARRIER; BRAIN GROWTH; CHROMOSOME DELETION; COGNITION; COMORBIDITY; COPY NUMBER VARIATION; GENETIC SUSCEPTIBILITY; HUMAN; LOCOMOTION; MATERNAL AGE; NERVE CELL PLASTICITY; NONHUMAN; NUTRITIONAL STATUS; OBSESSIVE COMPULSIVE DISORDER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; AUTISTIC DISORDER; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; PSYCHOTROPIC DRUGS; SIGNAL TRANSDUCTION;

EID: 84856092811     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.185     Document Type: Review

References (253)

1. Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002 Principal Investigators; Centers for Disease Control and Prevention (2007). Prevalence of autism spectrum disordersFautism and developmental disabilities monitoring network, 14 sites, United States, 2002. MMWR Surveill Summ 56: 12-28.
2. Abney M, McPeek MS, Ober C (2001). Broad and narrow heritabilities of quantitative traits in a founder population. Am J Hum Genet 68: 1302-1307. (Pubitemid 32424431)
3. Alarcon M, Abrahams BS, Stone JL, Duvall JA, Perederiy JV, Bomar JM et al (2008). Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet 82: 150-159. (Pubitemid 351726082)
4. American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders-Text Revision (DSM-IV-TR) 4th edn. American Psychiatric Association Press Inc.: Washington, DC.
5. Anagnostou E, Taylor MJ (2011). Review of neuroimaging in autism spectrum disorders: what have we learned and where we go from here. Mol Autism 2: 4.
6. Arking DE, Cutler DJ, Brune CW, Teslovich TM, West K, Ikeda M et al (2008). A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am J Hum Genet 82: 160-164. (Pubitemid 351726090)
7. Ashley CT, Wilkinson KD, Reines D, Warren ST (1993). FMR1 protein: conserved RNP family domains and selective RNA binding. Science 262: 563-566. (Pubitemid 23350668)
8. Aune TM, Golden HW, McGrath KM (1994). Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo. J Immunol 153: 489-498. (Pubitemid 24206278)
9. Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E et al (1995). Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 25: 63-78.
10. Bakkaloglu B, O0Roak BJ, Louvi A, Gupta AR, Abelson JF, Morgan TM et al (2008). Molecular cytogenetic analysis and resequencing of contactin associated protein-like 2 in autism spectrum disorders. Am J Hum Genet 82: 165-173. (Pubitemid 351735952)
11. Baranek GT, Boyd BA, Poe MD, David FJ, Watson LR (2007). Hyperresponsive sensory patterns in young children with autism, developmental delay, and typical development. Am J Ment Retard 112: 233-245.
12. Barnea-Goraly N, Lotspeich LJ, Reiss AL (2010). Similar white matter aberrations in children with autism and their unaffected siblings: a diffusion tensor imaging study using tract-based spatial statistics. Arch Gen Psychiatry 67: 1052-1060.
13. Baron-Cohen S (2010). Empathizing, systemizing, and the extreme male brain theory of autism. Prog Brain Res 186: 167-175.
14. Bear MF, Huber KM, Warren ST (2004). The mGluR theory of fragile X mental retardation. Trends Neurosci 27: 370-377. (Pubitemid 38829251)
15. Beaumont R, Sofronoff K (2008). A multi-component social skills intervention for children with Asperger syndrome: the Junior Detective Training Program. J Child Psychol Psychiatry 49: 743-753. (Pubitemid 351986242)
16. Benayed R, Gharani N, Rossman I, Mancuso V, Lazar G, Kamdar S et al (2005). Support for the homeobox transcription factor gene ENGRAILED 2 as an autism spectrum disorder susceptibility locus. Am J Hum Genet 77: 851-868. (Pubitemid 41513285)
17. Berkel S, Marshall CR, Weiss B, Howe J, Roeth R, Moog U et al (2010). Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat Genet 42: 489-491.
18. Betancur C (2011). Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res 1380: 42-77.
19. Bhogal B, Jongens TA (2010). Fragile X syndrome and model organisms: identifying potential routes of therapeutic intervention. Dis Model Mech 3: 693-700.
20. Bill BR, Geschwind DH (2009). Genetic advances in autism: heterogeneity and convergence on shared pathways. Curr Opin Genet Dev 19: 271-278.
21. Bolton P, Macdonald H, Pickles A, Rios P, Goode S, Crowson M et al (1994). A case-control family history study of autism. J Child Psychol Psychiatry 35: 877-900. (Pubitemid 24213267)
22. Bonnin A, Goeden N, Chen K, Wilson ML, King J, Shih JC et al (2011). A transient placental source of serotonin for the fetal forebrain. Nature 472: 347-350.
23. Bonnin A, Torii M, Wang L, Rakic P, Levitt P (2007). Serotonin modulates the response of embryonic thalamocortical axons to netrin-1. Nat Neurosci 10: 588-597. (Pubitemid 46652450)
24. Borea PA, Gessi S, Bar-Yehuda S, Fishman P (2009). A3 adenosine receptor: pharmacology and role in disease. Handb Exp Pharmacol 193: 297-327.
25. Bourgeron T (2009). A synaptic trek to autism. Curr Opin Neurobiol 19: 231-234.
26. Boyd BA, Baranek GT, Sideris J, Poe MD, Watson LR, Patten E et al (2010). Sensory features and repetitive behaviors in children with autism and developmental delays. Autism Res 3: 78-87.
27. Brand A, Vissiennon Z, Eschke D, Nieber K (2001). Adenosine A(1) and A(3) receptors mediate inhibition of synaptic transmission in rat cortical neurons. Neuropharmacology 40: 85-95. (Pubitemid 33779803)
28. Brune CW, Korvatska E, Allen-Brady K, Cook Jr EH, Dawson G, Devlin B et al (2008). Heterogeneous association between engrailed-2 and autism in the CPEA network. Am J Med Genet B Neuropsychiatr Genet 147B: 187-193. (Pubitemid 351355279)
29. Bucan M, Abrahams BS, Wang K, Glessner JT, Herman EI, Sonnenblick LI et al (2009). Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet 5: e1000536.
30. Buchmayer S, Johansson S, Johansson A, Hultman CM, Sparen P, Cnattingius S (2009). Can association between preterm birth and autism be explained by maternal or neonatal morbidity? Pediatrics 124: e817-e825.
31. Buie T, Campbell DB, Fuchs III GJ, Furuta GT, Levy J, Vandewater J et al (2010). Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics 125(Suppl 1): S1-18.
32. Butler MG, Dasouki MJ, Zhou XP, Talebizadeh Z, Brown M, Takahashi TN et al (2005). Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet 42: 318-321. (Pubitemid 40523954)
33. Campbell DB, Buie TM, Winter H, Bauman M, Sutcliffe JS, Perrin JM et al (2009). Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions. Pediatrics 123: 1018-1024.
34. Campbell DB, Sutcliffe JS, Ebert PJ, Militerni R, Bravaccio C, Trillo S et al (2006). A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci USA 103: 16834-16839. (Pubitemid 44737339)
35. Capuron L, Miller AH (2011). Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther 130: 226-238.
36. Careaga M, Van de Water J, Ashwood P (2010). Immune dysfunction in autism: a pathway to treatment. Neurotherapeutics 7: 283-292.
37. Carneiro AM, Blakely RD (2006). Serotonin-, protein kinase C-, and Hic-5-associated redistribution of the platelet serotonin transporter. J Biol Chem 281: 24769-24780. (Pubitemid 44274251)
38. Carneiro AM, Cook EH, Murphy DL, Blakely RD (2008). Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. J Clin Invest 118: 1544-1552. (Pubitemid 351500447)
39. Casanova MF, Buxhoeveden DP, Switala AE, Roy E (2002). Minicolumnar pathology in autism. Neurology 58: 428-432. (Pubitemid 34150918)
40. Cascio C, McGlone F, Folger S, Tannan V, Baranek G, Pelphrey KA et al (2008). Tactile perception in adults with autism: a multidimensional psychophysical study. J Autism Dev Disord 38: 127-137.
41. Chakrabarti S, Fombonne E (2005). Pervasive developmental disorders in preschool children: confirmation of high prevalence. Am J Psychiatry 162: 1133-1141. (Pubitemid 40770696)
42. Chanrion B, Mannoury la Cour C, Bertaso F, Lerner-Natoli M, Freissmuth M, Millan MJ et al (2007). Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity. Proc Natl Acad Sci USA 104: 8119-8124. (Pubitemid 47185885)
43. Chen R, Jiao Y, Herskovits EH (2011). Structural MRI in autism spectrum disorder. Pediatr Res 69(5 Part 2): 63R-68R.
44. Cheslack-Postava K, Liu K, Bearman PS (2011). Closely spaced pregnancies are associated with increased odds of autism in California sibling births. Pediatrics 127: 246-253.
45. Chess S (1971). Autism in children with congenital rubella. J Autism Child Schizophr 1: 33-47.
46. Chez MG, Chang M, Krasne V, Coughlan C, Kominsky M, Schwartz A (2006). Frequency of epileptiform EEG abnormalities in a sequential screening of autistic patients with no known clinical epilepsy from 1996 to 2005. Epilepsy Behav 8: 267-271. (Pubitemid 43103859)
47. Christian SL, Brune CW, Sudi J, Kumar RA, Liu S, Karamohamed S et al (2008). Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder. Biol Psychiatry 63: 1111-1117.
48. Chugani DC, Muzik O, Behen M, Rothermel R, Janisse JJ, Lee J et al (1999). Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann Neurol 45: 287-295. (Pubitemid 29120032)
49. Cleary C, Linde JA, Hiscock KM, Hadas I, Belmaker RH, Agam G et al (2008). Antidepressive-like effects of rapamycin in animal models: Implications for mTOR inhibition as a new target for treatment of affective disorders. Brain Res Bull 76: 469-473.
50. Consortium ECTS (1993). Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75: 1305-1315.
51. Constantino JN, Majmudar P, Bottini A, Arvin M, Virkud Y, Simons P et al (2010a). Infant head growth in male siblings of children with and without autism spectrum disorders. J Neurodev Disord 2: 39-46.
52. Constantino JN, Todd RD (2003). Autistic traits in the general population: a twin study. Arch Gen Psychiatry 60: 524-530. (Pubitemid 36539062)
53. Constantino JN, Zhang Y, Frazier T, Abbacchi AM, Law P (2010b). Sibling recurrence and the genetic epidemiology of autism. Am J Psychiatry 167: 1349-1356.
54. Cook E, Arora R, Anderson G, Berry-Kravis E, Yan S-Y, Yeoh H et al (1993). Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder. Life Sci 52: 2005-2015.
55. Cook E, Lindgren V, Leventhal B, Courchesne R, Lincoln A, Shulman C et al (1997). Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am J Hum Genet 60: 928-934. (Pubitemid 27146502)
56. Cook Jr EH, Fletcher KE, Wainwright M, Marks N, Yan SY, Leventhal BL (1994). Primary structure of the human platelet serotonin 5-HT2A receptor: identify with frontal cortex serotonin 5-HT2A receptor. J Neurochem 63: 465-469.
57. Coskun MA, Varghese L, Reddoch S, Castillo EM, Pearson DA, Loveland KA et al (2009). How somatic cortical maps differ in autistic and typical brains. Neuroreport 20: 175-179.
58. Costenia AR, Lopes LV, de Mendonca A, Ribeiro JA (2001). A functional role for adenosine A3 receptors: modulation of synaptic plasticity in the rat hippocampus. Neurosci Lett 302: 53-57. (Pubitemid 32244195)
59. Courchesne E, Campbell K, Solso S (2011). Brain growth across the life span in autism: age-specific changes in anatomical pathology. Brain Res 1380: 138-145.
60. Courchesne E, Carper R, Akshoomoff N (2003). Evidence of brain overgrowth in the first year of life in autism. JAMA 290: 337-344. (Pubitemid 37430519)
61. Courchesne E, Karns CM, Davis HR, Ziccardi R, Carper RA, Tigue ZD et al (2001). Unusual brain growth patterns in early life in patients with autistic disorder: an MRI study. Neurology 57: 245-254. (Pubitemid 32667357)
62. Courchesne E, Muller RA, Saitoh O (1999). Brain weight in autism: normal in the majority of cases, megalencephalic in rare cases. Neurology 52: 1057-1059. (Pubitemid 29161619)
63. Courchesne E, Pierce K (2005). Why the frontal cortex in autism might be talking only to itself: local over-connectivity but long-distance disconnection. Curr Opin Neurobiol 15: 225-230. (Pubitemid 41569273)
64. Croen LA, Grether JK, Yoshida CK, Odouli R, Hendrick V (2011). Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry (e-pub ahead of print 4 Jully 2011).
65. Cross S, Kim SJ, Weiss LA, Delahanty RJ, Sutcliffe JS, Leventhal BL et al (2008). Molecular genetics of the platelet serotonin system in first-degree relatives of patients with autism. Neuropsychopharmacology 33: 353-360. (Pubitemid 350243348)
66. Dalton KM, Nacewicz BM, Johnstone T, Schaefer HS, Gernsbacher MA, Goldsmith HH et al (2005). Gaze fixation and the neural circuitry of face processing in autism. Nat Neurosci 8: 519-526. (Pubitemid 41007571)
67. Dawson G, Rogers S, Munson J, Smith M, Winter J, Greenson J et al (2010). Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model. Pediatrics 125: e17-e23.
68. De Vrij FM, Levenga J, van der Linde HC, Koekkoek SK, De Zeeuw CI, Nelson DL et al (2008). Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice. Neurobiol Dis 31: 127-132. (Pubitemid 351822560)
69. Di Martino A, Ross K, Uddin LQ, Sklar AB, Castellanos FX, Milham MP (2009). Functional brain correlates of social and nonsocial processes in autism spectrum disorders: an activation likelihood estimation meta-analysis. Biol Psychiatry 65: 63-74.
70. Dolen G, Osterweil E, Rao BS, Smith GB, Auerbach BD, Chattarji S et al (2007). Correction of fragile X syndrome in mice. Neuron 56: 955-962. (Pubitemid 350251119)
71. Dunwiddle TV, Diao L, Kim HO, Jiang JL, Jacobson KA (1997). Activation of hippocampal adenosine A3 receptors produces a desensitization of A1 receptormediated responses in rat hippocampus. J Neurosci 17: 607-614. (Pubitemid 27024573)
72. Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F et al (2007). Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 39: 25-27. (Pubitemid 46026497)
73. Durkin MS, Maenner MJ, Newschaffer CJ, Lee LC, Cunniff CM, Daniels JL et al (2008). Advanced parental age and the risk of autism spectrum disorder. Am J Epidemiol 168: 1268-1276.
74. Duszak RS (2009). Congenital rubella syndromeFmajor review. Optometry 80: 36-43.
75. Eberhart DE, Malter HE, Feng Y, Warren ST (1996). The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Hum Mol Genet 5: 1083-1091. (Pubitemid 26318545)
76. Edwards DJ, Chugani DC, Chugani HT, Chehab J, Malian M, Aranda JV (2006). Pharmacokinetics of buspirone in autistic children. J Clin Pharmacol 46: 508-514.
77. Ehninger D, Han S, Shilyansky C, Zhou Y, Li W, Kwiatkowski DJ et al (2008a). Reversal of learning deficits in a Tsc2%+/mouse model of tuberous sclerosis. Nat Med 14: 843-848.
78. Ehninger D, Li W, Fox K, Stryker MP, Silva AJ (2008b). Reversing neurodevelopmental disorders in adults. Neuron 60: 950-960.
79. Elder LM, Dawson G, Toth K, Fein D, Munson J (2008). Head circumference as an early predictor of autism symptoms in younger siblings of children with autism spectrum disorder. J Autism Dev Disord 38: 1104-1111.
80. Erickson CA, Stigler KA, Corkins MR, Posey DJ, Fitzgerald JF, McDougle CJ (2005). Gastrointestinal factors in autistic disorder: a critical review. J Autism Dev Disord 35: 713-727.
81. Faraj BA, Olkowski ZL, Jackson RT (1994). Expression of a high-affinity serotonin transporter in human lymphocytes. Int J Immunopharmacol 16: 561-567. (Pubitemid 24193270)
82. Fatemi SH, Reutiman TJ, Folsom TD, Thuras PD (2009). GABA(A) receptor downregulation in brains of subjects with autism. J Autism Dev Disord 39: 223-230.
83. Folstein S, Rutter M (1977). Infantile autism: A genetic study of 21 twin pairs. J Child Psychol, Psychiatry 18: 297-321.
84. First twin study in ASD shows increased rate of concordance in monozygotic versus dizygotic twins. Fombonne E (2003). Epidemiological surveys of autism and other pervasive developmental disorders: an update. J Autism Dev Disord 33: 365-382. (Pubitemid 37127933)
85. Foss-Feig JH, Kwakye LD, Cascio CJ, Burnette CP, Kadivar H, Stone WL et al (2010). An extended multisensory temporal binding window in autism spectrum disorders. Exp Brain Res 203: 381-389.
86. Frazier TW, Hardan AY (2009). A meta-analysis of the corpus callosum in autism. Biol Psychiatry 66: 935-941.
87. Frye RE, Rossignol DA (2011). Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders. Pediatr Res 69(5 Part 2): 41R-47R.
88. Gardener H, Spiegelman D, Buka SL (2009). Prenatal risk factors for autism: comprehensive meta-analysis. Br J Psychiatry 195: 7-14.
89. Georgiades S, Szatmari P, Zwaigenbaum L, Duku E, Bryson S, Roberts W et al (2007). Structure of the autism symptom phenotype: a proposed multidimensional model. J Am Acad Child Adolesc Psychiatry 46: 188-196. (Pubitemid 46148417)
90. Gharani N, Benayed R, Mancuso V, Brzustowicz LM, Millonig JH (2004). Association of the homeobox transcription factor, ENGRAILED 2, 3, with autism spectrum disorder. Mol Psychiatry 9: 474-484. (Pubitemid 38903503)
91. Giulivi C, Zhang YF, Omanska-Klusek A, Ross-Inta C, Wong S, Hertz-Picciotto I et al (2010). Mitochondrial dysfunction in autism. JAMA 304: 2389-2396.
92. Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S et al (2009). Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459: 569-573.
93. Goffin A, Hoefsloot L, Bosgoed E, Swillen A, Fryns J-P (2001). PTEN mutation in a family with Cowden syndrome and autism. Am J Med Genet 105: 521-524. (Pubitemid 32729819)
94. Goldberg J, Anderson GM, Zwaigenbaum L, Hall GB, Nahmias C, Thompson A et al (2009). Cortical serotonin type-2 receptor density in parents of children with autism spectrum disorders. J Autism Dev Disord 39: 97-104.
95. Gordon C, State R, Nelson J, Hamburger S, Rapoport J (1993). A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Arch Gen Psychiatry 50: 441-447. (Pubitemid 23169937)
96. Gottesman II, Gould TD (2003). The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160: 636-645. (Pubitemid 41079594)
97. Gruss M, Braun K (2001). Alterations of amino acids and monoamine metabolism in male Fmr1 knockout mice: a putative animal model of the human fragile X mental retardation syndrome. Neural Plast 8: 285-298. (Pubitemid 34568204)
98. Guy J, Gan J, Selfridge J, Cobb S, Bird A (2007). Reversal of neurological defects in a mouse model of Rett syndrome. Science 315: 1143-1147. (Pubitemid 46328028)
99. Haas HL, Selbach O (2000). Functions of neuronal adenosine receptors. Naunyn Schmiedeberg's Arch Pharmacol 362: 375-381.
100. Hagerman RJ, Berry-Kravis E, Kaufmann WE, Ono MY, Tartaglia N, Lachiewicz A et al (2009). Advances in the treatment of fragile X syndrome. Pediatrics 123: 378-390.
101. Hall SS, Lightbody AA, Hirt M, Rezvani A, Reiss AL (2010). Autism in fragile X syndrome: a category mistake? J Am Acad Child Adolesc Psychiatry 49: 921-933.
102. Hamdan FF, Daoud H, Piton A, Gauthier J, Dobrzeniecka S, Krebs MO et al (2011). De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism. Biol Psychiatry 69: 898-901.
103. Hamdan FF, Gauthier J, Spiegelman D, Noreau A, Yang Y, Pellerin S et al (2009). Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. N Engl J Med 360: 599-605.
104. Hanley HG, Stahl SM, Freedman DX (1977). Hyperserotonemia and amine metabolites in autistic and retarded children. Arch Gen Psychiatry 34: 521-531. (Pubitemid 8108951)
105. Happe F, Frith U (2006). The weak coherence account: detail-focused cognitive style in autism spectrum disorders. J Autism Dev Disord 36: 5-25.
106. Harris SW, Hessl D, Goodlin-Jones B, Ferranti J, Bacalman S, Barbato I et al (2008). Autism profiles of males with fragile X syndrome. Am J Ment Retard 113: 427-438.
107. Hasko G, Linden J, Cronstein B, Pacher P (2008). Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 7: 759-770.
108. Hazlett HC, Poe M, Gerig G, Smith RG, Provenzale J, Ross A et al (2005). Magnetic resonance imaging and head circumference study of brain size in autism: birth through age 2 years. Arch Gen Psychiatry 62: 1366-1376. (Pubitemid 41746614)
109. Haznedar MM, Buchsbaum MS, Hazlett EA, LiCalzi EM, Cartwright C, Hollander E (2006). Volumetric analysis and three-dimensional glucose metabolic mapping of the striatum and thalamus in patients with autism spectrum disorders. Am J Psychiatry 163: 1252-1263. (Pubitemid 44464455)
110. Hessl D, Tassone F, Cordeiro L, Koldewyn K, McCormick C, Green C et al (2008). Brief report: aggression and stereotypic behavior in males with fragile X syndromeFmoderating secondary genes in a 'single gene' disorder. J Autism Dev Disord 38: 184-189.
111. Heulens I, Kooy F (2011). Fragile X syndrome: from gene discovery to therapy. Front Biosci 16: 1211-1232.
112. Hill EL (2004). Executive dysfunction in autism. Trends Cogn Sci 8: 26-32. (Pubitemid 38028515)
113. Hofstetter HH, Mossner R, Lesch KP, Linker RA, Toyka KV, Gold R (2005). Absence of reuptake of serotonin influences susceptibility to clinical autoimmune disease and neuroantigen-specific interferon-gamma production in mouse EAE. Clin Exp Immunol 142: 39-44. (Pubitemid 41361003)
114. Hollander E, Phillips A, Chaplin W, Zagursky K, Novotny S, Wasserman S et al (2005). A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology 30: 582-589. (Pubitemid 40271160)
115. Hrdlicka M, Komarek V, Propper L, Kulisek R, Zumrova A, Faladova L et al (2004). Not EEG abnormalities but epilepsy is associated with autistic regression and mental functioning in childhood autism. Eur Child Adolesc Psychiatry 13: 209-213. (Pubitemid 39279151)
116. Huber KM, Gallagher SM, Warren ST, Bear MF (2002). Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci USA 99: 7746-7750. (Pubitemid 34568762)
117. Hultman CM, Sandin S, Levine SZ, Lichtenstein P, Reichenberg A (2010). Advancing paternal age and risk of autism: new evidence from a populationbased study and a meta-analysis of epidemiological studies. Mol Psychiatry (e-pub ahead of print 3 November 2010).
118. Ibrahim SH, Voigt RG, Katusic SK, Weaver AL, Barbaresi WJ (2009). Incidence of gastrointestinal symptoms in children with autism: a population-based study. Pediatrics 124: 680-686.
119. International Molecular Genetic Study of Autism Consortium (2001). A genome wide screen for autism: strong evidence for linkage to chromosomes 2q, 7q and 16p. Am J Hum Genet 69: 570-581.
120. Jacob S, Landeros-Weisenberger A, Leckman JF (2009). Autism spectrum and obsessive-compulsive disorders: OC behaviors, phenotypes and genetics. Autism Res 2: 293-311.
121. Jacquemont S, Curie A, des Portes V, Torrioli MG, Berry-Kravis E, Hagerman RJ et al (2011). Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. Sci Transl Med 3: 64ra61.
122. Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, Gillberg IC et al (2003). Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 34: 27-29. (Pubitemid 36548785)
123. Jorde L, Hasstedt S, Ritvo E, Mason-Brothers A, Freeman B, Pingree C et al (1991). Complex segregation analysis of autism. Am J Hum Genet 49: 932-938. (Pubitemid 21891739)
124. Kanner L (1943). Autistic disturbances of affective contact. Nerv Child 2: 217-250.
125. Kilic F, Murphy D, Rudick G (2003). A human serotonin transporter mutation causes constitutive activation of transport activity. Mol Pharmacol 64: 440-446. (Pubitemid 36910008)
126. Kim HG, Kishikawa S, Higgins AW, Seong IS, Donovan DJ, Shen Y et al (2008). Disruption of neurexin 1 associated with autism spectrum disorder. Am J Hum Genet 82: 199-207. (Pubitemid 351735950)
127. Kim HL, Donnelly JH, Tournay AE, Book TM, Filipek P (2006). Absence of seizures despite high prevalence of epileptiform EEG abnormalities in children with autism monitored in a tertiary care center. Epilepsia 47: 394-398.
128. Kim JE, Lyoo IK, Estes AM, Renshaw PF, Shaw DW, Friedman SD et al (2010). Laterobasal amygdalar enlargement in 6-to 7-year-old children with autism spectrum disorder. Arch Gen Psychiatry 67: 1187-1197.
129. King BH, Hollander E, Sikich L, McCracken JT, Scahill L, Bregman JD et al (2009a). Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Arch Gen Psychiatry 66: 583-590.
130. King MD, Fountain C, Dakhlallah D, Bearman PS (2009b). Estimated autism risk and older reproductive age. Am J Public Health 99: 1673-1679.
131. Kingwood K (2011). Psychiatric disorders: the stresses of womanhood. Nature Rev Neurosci 12: 185.
132. Kleinhans NM, Johnson LC, Richards T, Mahurin R, Greenson J, Dawson G et al (2009). Reduced neural habituation in the amygdala and social impairments in autism spectrum disorders. Am J Psychiatry 166: 467-475.
133. Kremer EJ, Pritchard M, Lynch M, Yu S, Holman K, Baker E et al (1991). Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science 252: 1711-1714. (Pubitemid 21917094)
134. Kumar RA, KaraMohamed S, Sudi J, Conrad DF, Brune C, Badner JA et al (2008). Recurrent 16p11.2 microdeletions in autism. Hum Mol Genet 17: 628-638. (Pubitemid 351201774)
135. Kwakye LD, Foss-Feig JH, Cascio CJ, Stone WL, Wallace MT (2011). Altered auditory and multisensory temporal processing in autism spectrum disorders. Front Integr Neurosci 4: 129.
136. Kwon CH, Luikart BW, Powell CM, Zhou J, Matheny SA, Zhang W et al (2006). Pten regulates neuronal arborization and social interaction in mice. Neuron 50: 377-388.
137. Lam KS, Bodfish JW, Piven J (2008). Evidence for three subtypes of repetitive behavior in autism that differ in familiality and association with other symptoms. J Child Psychol Psychiatry 49: 1193-1200.
138. Langen M, Durston S, Staal WG, Palmen SJ, van Engeland H (2007). Caudate nucleus is enlarged in high-functioning medication-naive subjects with autism. Biol Psychiatry 62: 262-266. (Pubitemid 47042019)
139. Langen M, Schnack HG, Nederveen H, Bos D, Lahuis BE, de Jonge MV et al (2009). Changes in the developmental trajectories of striatum in autism. Biol Psychiatry 66: 327-333.
140. Lesch KP, Wolozin BL, Murphy DL, Riederer P (1993). Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochemi 60: 2319-2322. (Pubitemid 23148809)
141. Levenga J, Hayashi S, de Vrij FM, Koekkoek SK, van der Linde HC, Nieuwenhuizen I et al (2011). AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome. Neurobiol Dis 42: 311-317.
142. Levitt P, Campbell DB (2009). The genetic and neurobiologic compass points toward common signaling dysfunctions in autism spectrum disorders. J Clin Invest 119: 747-754.
143. Leyfer OT, Folstein SE, Bacalman S, Davis NO, Dinh E, Morgan J et al (2006). Comorbid psychiatric disorders in children with autism: interview development and rates of disorders. J Autism Dev Disord 36: 849-861. (Pubitemid 44440104)
144. Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M et al (2010). mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329: 959-964.
145. Li W, Cui Y, Kushner SA, Brown RA, Jentsch JD, Frankland PW et al (2005). The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr Biol 15: 1961-1967. (Pubitemid 41566145)
146. Lichtenstein P, Carlstrom E, Rastam M, Gillberg C, Anckarsater H (2010). The genetics of autism spectrum disorders and related neuropsychiatric disorders in childhood. Am J Psychiatry 167: 1357-1363.
147. Limperopoulos C, Bassan H, Sullivan NR, Soul JS, Robertson Jr RL, Moore M et al (2008). Positive screening for autism in ex-preterm infants: prevalence and risk factors. Pediatrics 121: 758-765.
148. Loesch DZ, Bui QM, Dissanayake C, Clifford S, Gould E, Bulhak-Paterson D et al (2007). Molecular and cognitive predictors of the continuum of autistic behaviours in fragile X. Neurosci Biobehav Rev 31: 315-326. (Pubitemid 46241448)
149. Macek TA, Schaffhauser H, Conn PJ (1998). Protein kinase C and A3 adenosine receptor activation inhibit presynaptic metabotropic glutamate receptor (mGluR) function and uncouple mGluRs from GTP-binding proteins. J Neurosci 18: 6138-6146. (Pubitemid 28373222)
150. Marco EJ, Hinkley LB, Hill SS, Nagarajan SS (2011). Sensory processing in autism: a review of neurophysiologic findings. Pediatr Res 69(5 Part 2): 48R-54R.
151. Marcus RN, Owen R, Kamen L, Manos G, McQuade RD, Carson WH et al (2009). A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry 48: 1110-1119.
152. Mattila ML, Hurtig T, Haapsamo H, Jussila K, Kuusikko-Gauffin S, Kielinen M et al (2010). Comorbid psychiatric disorders associated with Asperger syndrome/high-functioning autism: a community-and clinic-based study. J Autism Dev Disord 40: 1080-1093.
153. McBride PA, Anderson GM, Hertzig ME, Sweeney JA, Kream J, Cohen DJ et al (1989). Serotonergic responsivity in male young adults with autistic disorder. Arch Gen Psychiatry 46: 205-212.
154. McCauley JL, Olson LM, Dowd M, Amin T, Steele A, Blakely RD et al (2004). Linkage and association analysis at the serotonin transporter (SLC6A4) locus in a rigid-compulsive subset of autism. Am J Med Genet B Neuropsychiatr Genet 127: 104-112. (Pubitemid 38542324)
155. McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG et al (2002). Risperidone in children with autism and serious behavioral problems. N Engl J Med 347: 314-321. (Pubitemid 34815353)
156. McDougle C, Naylor S, Cohen D, Volkmar F, Heninger G, Price L (1996). A doubleblind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry 53: 1001-1008. (Pubitemid 26384669)
157. McDougle CJ, Naylor ST, Goodman WK, Volkmar FR, Cohen DJ, Price LH (1993). Acute tryptophan depletion in autistic disorder: a controlled case study. Biol Psychiatry 33: 547-550. (Pubitemid 23167223)
158. McDougle CJ, Scahill L, Aman MG, McCracken JT, Tierney E, Davies M et al (2005). Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry 162: 1142-1148. (Pubitemid 40770697)
159. McPheeters ML, Warren Z, Sathe N, Bruzek JL, Krishnaswami S, Jerome RN et al (2011). A systematic review of medical treatments for children with autism spectrum disorders. Pediatrics 127: e1312-e1321.
160. Meredith EJ, Holder MJ, Chamba A, Challa A, Drake Lee A, Bunce CM et al (2005). The serotonin transporter (SLC6A4) is present in B-cell clones of diverse malignant origin: probing a potential antitumor target for psychotropics. FASEB J 19: 1187-1189. (Pubitemid 40946460)
161. Mosconi MW, Cody-Hazlett H, Poe MD, Gerig G, Gimpel-Smith R, Piven J (2009). Longitudinal study of amygdala volume and joint attention in 2-to 4-year-old children with autism. Arch Gen Psychiatry 66: 509-516.
162. Mulder EJ, Anderson GM, Kema IP, de Bildt A, van Lang ND, den Boer JA et al (2004). Platelet serotonin levels in pervasive developmental disorders and mental retardation: diagnostic group differences, within-group distribution, and behavioral correlates. J Am Acad Child Adolesc Psychiatry 43: 491-499. (Pubitemid 38812390)
163. Munson J, Dawson G, Sterling L, Beauchaine T, Zhou A, Elizabeth K et al (2008). Evidence for latent classes of IQ in young children with autism spectrum disorder. Am J Ment Retard 113: 439-452.
164. Murphy DG, Daly E, Schmitz N, Toal F, Murphy K, Curran S et al (2006). Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: an in vivo SPECT study. Am J Psychiatry 163: 934-936. (Pubitemid 44464547)
165. Nacewicz BM, Dalton KM, Johnstone T, Long MT, McAuliff EM, Oakes TR et al (2006). Amygdala volume and nonverbal social impairment in adolescent and adult males with autism. Arch Gen Psychiatry 63: 1417-1428. (Pubitemid 44878525)
166. Nakamura K, Sekine Y, Ouchi Y, Tsujii M, Yoshikawa E, Futatsubashi M et al (2010). Brain serotonin and dopamine transporter bindings in adults with highfunctioning autism. Arch Gen Psychiatry 67: 59-68.
167. Network RUoPPA (2005). Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry 62: 1266-1274.
168. Noor A, Whibley A, Marshall CR, Gianakopoulos PJ, Piton A, Carson AR et al (2010). Disruption at the PTCHD1 locus on Xp22.11 in autism spectrum disorder and intellectual disability. Sci Transl Med 2: 49ra68.
169. Numis AL, Major P, Montenegro MA, Muzykewicz DA, Pulsifer MB, Thiele EA (2011). Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex. Neurology 76: 981-987.
170. Oblak AL, Gibbs TT, Blatt GJ (2011). Reduced GABAA receptors and benzodiazepine binding sites in the posterior cingulate cortex and fusiform gyrus in autism. Brain Res 1380: 218-228.
171. Oliveira G, Diogo L, Grazina M, Garcia P, Ataide A, Marques C et al (2005). Mitochondrial dysfunction in autism spectrum disorders: a population-based study. Dev Med Child Neurol 47: 185-189. (Pubitemid 40277824)
172. Ozaki N, Goldman D, Kaye W, Plotnikov K, Greenberg B, Rudnick G et al (2003). A missense mutation in the serotonin transporter is associated with a complex neuropsychiatric phenotype. Mol Psychiatry 8: 933-936. (Pubitemid 37421700)
173. Ozonoff S, Iosif AM, Baguio F, Cook IC, Hill MM, Hutman T et al (2010). A prospective study of the emergence of early behavioral signs of autism. J Am Acad Child Adolesc Psychiatry 49: 256-266. e251-252.
174. Page DT, Kuti OJ, Prestia C, Sur M (2009). Haploinsufficiency for Pten and serotonin transporter cooperatively influences brain size and social behavior. Proc Natl Acad Sci USA 106: 1989-1994.
175. Panerai S, Zingale M, Trubia G, Finocchiaro M, Zuccarello R, Ferri R et al (2009). Special education versus inclusive education: the role of the TEACCH program. J Autism Dev Disord 39: 874-882.
176. Parikh MS, Kolevzon A, Hollander E (2008). Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability. J Child Adolesc Psychopharmacol 18: 157-178. (Pubitemid 351591438)
177. Patterson PH (2011). Modeling autistic features in animals. Pediatr Res 69(5 Part 2): 34R-40R.
178. Penagarikano O, Mulle JG, Warren ST (2007). The pathophysiology of fragile X syndrome. Annu Rev Genomics Hum Genet 8: 109-129.
179. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R et al (2010). Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466: 368-372.
180. Piton A, Michaud JL, Peng H, Aradhya S, Gauthier J, Mottron L et al (2008). Mutations in the calcium-related gene IL1RAPL1 are associated with autism. Hum Mol Genet 17: 3965-3974. (Pubitemid 352762857)
181. Prasad HC, Steiner JA, Sutcliffe JS, Blakely RD (2009). Enhanced activity of human serotonin transporter variants associated with autism. Philos Trans R Soc Lond B Biol Sci 364: 163-173.
182. Prasad HC, Zhu CB, McCauley JL, Samuvel DJ, Ramamoorthy S, Shelton RC et al (2005). Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase. Proc Natl Acad Sci USA 102: 11545-11550. (Pubitemid 41153856)
183. Prasad PD, Hoffmans BJ, Moe AJ, Smith CH, Leibach FH, Ganapathy V (1996). Functional expression of the plasma membrane serotonin transporter but not the vesicular monoamine transporter in human placental trophoblasts and choriocarcinoma cells. Placenta 17: 201-207. (Pubitemid 26166910)
184. Quick MW (2003). Regulating the conducting states of a mammalian serotonin transporter. Neuron 40: 537-549. (Pubitemid 37494703)
185. Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS et al (1993). Antidepressant-and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 90: 2542-2546. (Pubitemid 23078664)
186. Ramocki MB, Zoghbi HY (2008). Failure of neuronal homeostasis results in common neuropsychiatric phenotypes. Nature 455: 912-918.
187. Redcay E, Courchesne E (2005). When is the brain enlarged in autism? A metaanalysis of all brain size reports. Biol Psychiatry 58: 1-9. (Pubitemid 40909929)
188. Ressler KJ, Mercer KB, Bradley B, Jovanovic T, Mahan A, Kerley K et al (2011). Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature 470: 492-497.
189. Richler J, Bishop SL, Kleinke JR, Lord C (2007). Restricted and repetitive behaviors in young children with autism spectrum disorders. J Autism Dev Disord 37: 73-85. (Pubitemid 46197896)
190. Richler J, Huerta M, Bishop SL, Lord C (2010). Developmental trajectories of restricted and repetitive behaviors and interests in children with autism spectrum disorders. Dev Psychopathol 22: 55-69.
191. Ritvo E, Jorde L, Mason-Brothers A, Freeman B, Pingree C, Jones M et al (1989). The UCLA-University of Utah epidemiologic survey of autism: recurrence risk estimates and genetic counseling. Am J Psychiatry 146: 1032-1036. (Pubitemid 19197982)
192. Rivkees SA, Thevananther S, Hao H (2000). Are A3 adenosine receptors expressed in the brain? Neuroreport 11: 1025-1030. (Pubitemid 30235450)
193. Rosenberg RE, Law JK, Yenokyan G, McGready J, Kaufmann WE, Law PA (2009). Characteristics and concordance of autism spectrum disorders among 277 twin pairs. Arch Pediatr Adolesc Med 163: 907-914.
194. Rubenstein JL, Merzenich MM (2003). Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav 2: 255-267. (Pubitemid 37345664)
195. Salichon N, Gaspar P, Upton AL, Picaud S, Hanoun N, Hamon M et al (2001). Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-ht transporter knockout mice. J Neurosci 21: 884-896. (Pubitemid 32163130)
196. Samuvel DJ, Jayanthi LD, Bhat NR, Ramamoorthy S (2005). A role for p38 mitogenactivated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression. J Neurosci 25: 29-41. (Pubitemid 40110763)
197. Schain RJ, Freedman DX (1961). Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J Pediatrics 58: 315-320.
198. Schendel D, Bhasin TK (2008). Birth weight and gestational age characteristics of children with autism, including a comparison with other developmental disabilities. Pediatrics 121: 1155-1164.
199. Schieve LA, Baio J, Rice CE, Durkin M, Kirby RS, Drews-Botsch C et al (2010). Risk for cognitive deficit in a population-based sample of US children with autism spectrum disorders: variation by perinatal health factors. Disabil Health J 3: 202-212.
200. Schumann CM, Barnes CC, Lord C, Courchesne E (2009). Amygdala enlargement in toddlers with autism related to severity of social and communication impairments. Biol Psychiatry 66: 942-949.
201. Schumann CM, Bloss CS, Barnes CC, Wideman GM, Carper RA, Akshoomoff N et al (2010). Longitudinal magnetic resonance imaging study of cortical development through early childhood in autism. J Neurosci 30: 4419-4427.
202. Sears LL, Vest C, Mohamed S, Bailey J, Ranson BJ, Piven J (1999). An MRI study of the basal ganglia in autism. Prog Neuropsychopharmacol Biol Psychiatry 23: 613-624. (Pubitemid 29268406)
203. Sharma A, Hoeffer CA, Takayusa Y, Miyawaki T, McBride SM, Klann E et al (2010). Dysregulation of mTOR signaling in fragile X syndrome. J Neurosci 30: 694-702.
204. Shukla DK, Keehn B, Lincoln AJ, Muller RA (2010). White matter compromise of callosal and subcortical fiber tracts in children with autism spectrum disorder: a diffusion tensor imaging study. J Am Acad Child Adolesc Psychiatry 49: 1269-1278, 1278.e1261-1262.
205. Shumway S, Thurm A, Swedo SE, Deprey L, Barnett LA, Amaral DG et al (2011). Brief report: symptom onset patterns and functional outcomes in young children with autism spectrum disorders. J Autism Dev Disord (e-pub ahead of print 1 March 2011).
206. Silverman JL, Tolu SS, Barkan CL, Crawley JN (2010). Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP. Neuropsychopharmacology 35: 976-989.
207. Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G (2008). Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry 47: 921-929.
208. Skuse D, James R, Bishop D, Coppin B, Dalton P, Aamodt-Leeper G et al (1997). Evidence from Turner's syndrome of an imprinted X-linked locus affecting cognitive function. Nature 387: 705-708. (Pubitemid 27270610)
209. Skuse DH, Mandy WP, Scourfield J (2005). Measuring autistic traits: heritability, reliability and validity of the Social and Communication Disorders Checklist. Br J Psychiatry 187: 568-572. (Pubitemid 41752747)
210. Smith CJ, Lang CM, Kryzak L, Reichenberg A, Hollander E, Silverman JM (2009). Familial associations of intense preoccupations, an empirical factor of the restricted, repetitive behaviors and interests domain of autism. J Child Psychol Psychiatry 50: 982-990.
211. Smith T, Groen AD, Wynn JW (2000). Randomized trial of intensive early intervention for children with pervasive developmental disorder. Am J Ment Retard 105: 269-285. (Pubitemid 30637448)
212. Soll C, Jang JH, Reiner MO, Moritz W, Wild PJ, Graph R et al (2010). Serotonin promotes tumor growth in human hepatocellular cancer. Hepatology 51: 1244-1254.
213. Stanfield AC, McIntosh AM, Spencer MD, Philip R, Gaur S, Lawrie SM (2008). Towards a neuroanatomy of autism: a systematic review and meta-analysis of structural magnetic resonance imaging studies. Eur Psychiatry 23: 289-299. (Pubitemid 351938706)
214. State MW (2011). The genetics of child psychiatric disorders: focus on autism and Tourette syndrome. Neuron 68: 254-269.
215. Steiner JA, Carneiro AM, Wright J, Matthies HJ, Prasad HC, Nicki CK et al (2009). cGMP-dependent protein kinase Ialpha associates with the antidepressantsensitive serotonin transporter and dictates rapid modulation of serotonin uptake. Mol Brain 2: 26.
216. Stone JL, Merriman B, Cantor RM, Yonan AL, Gilliam TC, Geschwind DH et al (2004). Evidence for sex-specific risk alleles in autism spectrum disorder. Am J Hum Genet 75: 1117-1123. (Pubitemid 39532079)
217. Stromland K, Nordin V, Miller M, Akerstrom B, Gillberg C (1994). Autism in thalidomide embryopathy: a population study. Dev Med Child Neurol 36: 351-356. (Pubitemid 24088565)
218. Su T, Fan HX, Jiang T, Sun WW, Den WY, Gao MM et al (2011). Early continuous inhibition of group 1 mGlu signaling partially rescues dendritic spine abnormalities in the Fmr1 knockout mouse model for fragile X syndrome. Psychopharmacology (Berl) 215: 291-300.
219. Sudhof TC (2008). Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455: 903-911.
220. Sutcliffe JS, Delahanty RJ, Prasad HC, McCauley JL, Han Q, Jiang L et al (2005). Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am J Hum Genet 77: 265-279. (Pubitemid 41022709)
221. Suvrathan A, Hoeffer CA, Wong H, Klann E, Chattarji S (2010). Characterization and reversal of synaptic defects in the amygdala in a mouse model of fragile X syndrome. Proc Natl Acad Sci USA 107: 11591-11596.
222. Tadevosyan-Leyfer O, Dowd M, Mankoski R, Winklosky B, Putnam S, McGrath L et al (2003). A principal components analysis of the Autism Diagnostic InterviewFRevised. J Am Acad Child Adolesc Psychiatry 42: 864-872. (Pubitemid 39571851)
223. Taliani S, Pugliese I, Bellandi M, La Motta C, Da Settimo F (2010). A3 receptor ligands: past, present and future trends. Curr Top Med Chem 10: 942-975.
224. Tommerdahl M, Tannan V, Cascio CJ, Baranek GT, Whitsel BL (2007). Vibrotactile adaptation fails to enhance spatial localization in adults with autism. Brain Res 1154: 116-123. (Pubitemid 46856352)
225. Tropea D, Giacometti E, Wilson NR, Beard C, McCurry C, Fu DD et al (2009). Partial reversal of Rett syndrome-like symptoms in MeCP2 mutant mice. Proc Natl Acad Sci USA 106: 2029-2034.
226. Van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S et al (1997). Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277: 805-808. (Pubitemid 27366729)
227. Van Woerden GM, Harris KD, Hojjati MR, Gustin RM, Qiu S, de Avila Freire R et al (2007). Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of alphaCaMKII inhibitory phosphorylation. Nat Neurosci 10: 280-282.
228. Volkmar F, Cook Jr E, Pomeroy J, Realmuto G, Tanguay P (1999). Summary of the practice parameters for the assessment and treatment of children, adolescents, and adults with autism and other pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry 38: 1611-1616.
229. Wang K, Zhang H, Ma D, Bucan M, Glessner JT, Abrahams BS et al (2009). Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 459: 528-533.
230. Wang LW, Tancredi DJ, Thomas DW (2011). The prevalence of gastrointestinal problems in children across the United States with autism spectrum disorders from families with multiple affected members. J Dev Behav Pediatr 32: 351-360.
231. Warren Z, McPheeters ML, Sathe N, Foss-Feig JH, Glasser A, Veenstra-Vanderweele J (2011). A systematic review of early intensive intervention for autism spectrum disorders. Pediatrics 127: e1303-e1311.
232. Wassink TH, Hazlett HC, Epping EA, Arndt S, Dager SR, Schellenberg GD et al (2007). Cerebral cortical gray matter overgrowth and functional variation of the serotonin transporter gene in autism. Arch Gen Psychiatry 64: 709-717. (Pubitemid 46878671)
233. Waterhouse L, Morris R, Allen D, Dunn M, Fein D, Feinstein C et al (1996). Diagnosis and classification in autism. J Autism Dev Disord 26: 59-86. (Pubitemid 26076058)
234. Weiss LA (2009). Autism genetics: emerging data from genome-wide copynumber and single nucleotide polymorphism scans. Expert Rev Mol Diagn 9: 795-803.
235. Weiss LA, Abney M, Cook Jr EH, Ober C (2005). Sex-specific genetic architecture of whole blood serotonin levels. Am J Hum Genet 76: 33-41. (Pubitemid 40023763)
236. Weiss LA, Arking DE, Daly MJ, Chakravarti A (2009). A genome-wide linkage and association scan reveals novel loci for autism. Nature 461: 802-808.
237. Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, Fossdal R et al (2008). Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 358: 667-675. (Pubitemid 351240746)
238. Weiss LA, Veenstra-Vanderweele J, Newman DL, Kim SJ, Dytch H, McPeek MS et al (2004). Genome-wide association study identifies ITGB3 as a QTL for whole blood serotonin. Eur J Hum Genet 12: 949-954. (Pubitemid 39462129)
239. Weng SJ, Carrasco M, Swartz JR, Wiggins JL, Kurapati N, Liberzon I et al (2011). Neural activation to emotional faces in adolescents with autism spectrum disorders. J Child Psychol Psychiatry 52: 296-305.
240. Werner E, Dawson G (2005). Validation of the phenomenon of autistic regression using home videotapes. Arch Gen Psychiatry 62: 889-895. (Pubitemid 41126883)
241. Williams G, King J, Cunningham M, Stephan M, Kerr B, Hersh JH (2001). Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol 43: 202-206. (Pubitemid 32233082)
242. Wisniowiecka-Kowalnik B, Nesteruk M, Peters SU, Xia Z, Cooper ML, Savage S et al (2010). Intragenic rearrangements in NRXN1 in three families with autism spectrum disorder, developmental delay, and speech delay. Am J Med Genet B Neuropsychiatr Genet 153B: 983-993.
243. Wood JJ, Drahota A, Sze K, Har K, Chiu A, Langer DA (2009). Cognitive behavioral therapy for anxiety in children with autism spectrum disorders: a randomized, controlled trial. J Child Psychol Psychiatry 50: 224-234.
244. Yan QJ, Rammal M, Tranfaglia M, Bauchwitz RP (2005). Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP. Neuropharmacology 49: 1053-1066. (Pubitemid 41503304)
245. Yoder PJ, Lieberman RG (2010). Brief report: randomized test of the efficacy of picture exchange communication system on highly generalized picture exchanges in children with ASD. J Autism Dev Disord 40: 629-632.
246. Young MR, Kut JL, Coogan MP, Wright MA, Young ME, Matthews J (1993). Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low-dose exogenous serotonin. Immunology 80: 395-400. (Pubitemid 23336688)
247. Zhang YQ, Friedman DB, Wang Z, Woodruff 3rd E, Pan L, O0Donnell J et al (2005). Protein expression profiling of the Drosophila fragile X mutant brain reveals upregulation of monoamine synthesis. Mol Cell Proteomics 4: 278-290. (Pubitemid 40439771)
248. Zhao X, Leotta A, Kustanovich V, Lajonchere C, Geschwind DH, Law K et al (2007). A unified genetic theory for sporadic and inherited autism. Proc Natl Acad Sci USA 104: 12831-12836. (Pubitemid 47255240)
249. Zhou J, Blundell J, Ogawa S, Kwon CH, Zhang W, Sinton C et al (2009). Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knockout mice. J Neurosci 29: 1773-1783.
250. Zhu C, Lindler KM, Campbell NG, Sutcliffe JS, Hewlett WA, Blakely RD (2011). Colocalization and regulated physical association of presynaptic serotonin transporters with A3 adenosine receptors. Mol Pharm 80: 458-465.
251. Zhu CB, Carneiro AM, Dostmann WR, Hewlett WA, Blakely RD (2005). p38 MAPK activation elevates serotonin transport activity via a traffickingindependent, protein phosphatase 2A-dependent process. J Biol Chem 280: 15649-15658. (Pubitemid 40616683)
252. Zhu CB, Lindler KM, Owens AW, Daws LC, Blakely RD, Hewlett WA (2010). Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters. Neuropsychopharmacology 35: 2510-2520.
253. Zhu CB, Steiner JA, Munn JL, Daws LC, Hewlett WA, Blakely RD (2007). Rapid stimulation of presynaptic serotonin transport by A(3) adenosine receptors. J Pharmacol Exp Ther 322: 332-340. (Pubitemid 46956381)